GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dizal (Jiangsu) Pharmaceutical Co Ltd (SHSE:688192) » Definitions » Operating Margin %

Dizal (Jiangsu) Pharmaceutical Co (SHSE:688192) Operating Margin % : -275.77% (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Dizal (Jiangsu) Pharmaceutical Co Operating Margin %?

Operating Margin % is calculated as Operating Income divided by its Revenue. Dizal (Jiangsu) Pharmaceutical Co's Operating Income for the three months ended in Mar. 2024 was ¥-224.3 Mil. Dizal (Jiangsu) Pharmaceutical Co's Revenue for the three months ended in Mar. 2024 was ¥81.3 Mil. Therefore, Dizal (Jiangsu) Pharmaceutical Co's Operating Margin % for the quarter that ended in Mar. 2024 was -275.77%.

The historical rank and industry rank for Dizal (Jiangsu) Pharmaceutical Co's Operating Margin % or its related term are showing as below:

SHSE:688192' s Operating Margin % Range Over the Past 10 Years
Min: -6464.75   Med: -1231.58   Max: -477.77
Current: -638.87


SHSE:688192's Operating Margin % is ranked worse than
93.71% of 1017 companies
in the Drug Manufacturers industry
Industry Median: 6.13 vs SHSE:688192: -638.87

Dizal (Jiangsu) Pharmaceutical Co's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

Dizal (Jiangsu) Pharmaceutical Co's Operating Income for the three months ended in Mar. 2024 was ¥-224.3 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-1,102.7 Mil.


Dizal (Jiangsu) Pharmaceutical Co Operating Margin % Historical Data

The historical data trend for Dizal (Jiangsu) Pharmaceutical Co's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dizal (Jiangsu) Pharmaceutical Co Operating Margin % Chart

Dizal (Jiangsu) Pharmaceutical Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Operating Margin %
Get a 7-Day Free Trial -1,097.96 -2,738.97 -6,464.75 - -1,231.58

Dizal (Jiangsu) Pharmaceutical Co Quarterly Data
Dec18 Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - -793.12 -544.00 -275.77

Competitive Comparison of Dizal (Jiangsu) Pharmaceutical Co's Operating Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Dizal (Jiangsu) Pharmaceutical Co's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dizal (Jiangsu) Pharmaceutical Co's Operating Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dizal (Jiangsu) Pharmaceutical Co's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Dizal (Jiangsu) Pharmaceutical Co's Operating Margin % falls into.



Dizal (Jiangsu) Pharmaceutical Co Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Dizal (Jiangsu) Pharmaceutical Co's Operating Margin % for the fiscal year that ended in Dec. 2023 is calculated as

Operating Margin %=Operating Income (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=-1124.296 / 91.289
=-1,231.58 %

Dizal (Jiangsu) Pharmaceutical Co's Operating Margin % for the quarter that ended in Mar. 2024 is calculated as

Operating Margin %=Operating Income (Q: Mar. 2024 ) / Revenue (Q: Mar. 2024 )
=-224.25 / 81.319
=-275.77 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Dizal (Jiangsu) Pharmaceutical Co  (SHSE:688192) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Dizal (Jiangsu) Pharmaceutical Co Operating Margin % Related Terms

Thank you for viewing the detailed overview of Dizal (Jiangsu) Pharmaceutical Co's Operating Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Dizal (Jiangsu) Pharmaceutical Co (SHSE:688192) Business Description

Traded in Other Exchanges
N/A
Address
Jinghui East Road, Room 4105, Building E (Building 5), Huirong Business Plaza, Xinwu District, Jiangsu Province, Wuxi City, CHN, 201203
Dizal (Jiangsu) Pharmaceutical Co Ltd is engaged in the research and development, production and sales of innovative drugs.
Executives
Wu Qing Yi senior management
Lv Hong Bin senior management
Directors, senior managers
Directors, senior managers, core technical personn
Senior management, core technical personnel
Zheng Li Core technical personnel
Yang Zhen Fan Senior management, core technical personnel
Senior management, core technical personnel
Qiao Wei Jun Core technical personnel
Chen Kan Core technical personnel
Chen Su Qin Senior management, core technical personnel
Zhang Zhi Wei senior management
Senior management, core technical personnel
Senior management, core technical personnel

Dizal (Jiangsu) Pharmaceutical Co (SHSE:688192) Headlines

No Headlines